{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T13:14:28Z","timestamp":1762521268625,"version":"build-2065373602"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:00:00Z","timestamp":1762473600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:00:00Z","timestamp":1762473600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Posterior reversible encephalopathy syndrome (PRES) is an acute or subacute neurological syndrome with clinical manifestations including headache, vision loss, altered mental status, and seizures. Magnetic resonance imaging(MRI) can assist in clarifying the diagnosis. Systemic lupus erythematosus (SLE) is an autoimmune disease, and the occurrence of PRES is infrequent, especially in children with SLE.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case description<\/jats:title>\n                    <jats:p>Our patient was initially diagnosed with juvenile systemic lupus erythematosus involving the skin, joints, and kidneys. The patient was treated with glucocorticoids and cyclophosphamide, which led to a partial improvement in symptoms. However, the patient experienced neurological symptoms and elevated blood pressure, and head MRI revealed swelling and diffuse damage to the bilateral occipital parietal gyrus. The patient was diagnosed with PRES.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The symptoms were relieved after actively lowering blood pressure, dehydrating with mannitol, and treating with glucocorticoids, cyclophosphamide, and telitacicept. Six months later, no abnormalities were observed in the follow-up head MR image. We searched PubMed to review the characteristics of 15 children with SLE who developed PRES, and most of them recovered after active treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Various factors can lead to complications of PRES in paediatric patients with systemic lupus erythematosus. In our patient, the likely cause was the high disease activity of SLE. This review revealed that juvenile SLE cases accompanied by PRES are often associated with lupus nephritis, hypertension, and high disease activity. Most patients recover with timely and active treatment, with only a few experiencing recurrence.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13023-025-04044-0","type":"journal-article","created":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T13:06:08Z","timestamp":1762520768000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Juvenile systemic lupus erythematosus complicated with posterior reversible encephalopathy syndrome: a case report and literature review"],"prefix":"10.1186","volume":"20","author":[{"given":"Man","family":"Luo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huan","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Long","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Changming","family":"Xia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"GuoHua","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fang","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,7]]},"reference":[{"issue":"23","key":"4044_CR1","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.1056\/NEJMra2114482","volume":"388","author":"RG Geocadin","year":"2023","unstructured":"Geocadin RG. Posterior reversible encephalopathy syndrome. N Engl J Med. 2023;388(23):2171\u20138. https:\/\/doi.org\/10.1056\/NEJMra2114482.","journal-title":"N Engl J Med"},{"issue":"8","key":"4044_CR2","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1056\/NEJM199602223340803","volume":"22","author":"J Hinchey","year":"1996","unstructured":"Hinchey J, Chaves C, Appignani B, Breen J, Pao L, Wang A, et al. A reversible posterior leukoencephalopathy syndrome. N Engl J Med. 1996;22(8):494\u2013500. https:\/\/doi.org\/10.1056\/NEJM199602223340803.","journal-title":"N Engl J Med"},{"issue":"1","key":"4044_CR3","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1097\/WCO.0000000000000640","volume":"32","author":"TG Liman","year":"2019","unstructured":"Liman TG, Siebert E, Endres M. Posterior reversible encephalopathy syndrome. Curr Opin Neurol. 2019;32(1):25\u201335. https:\/\/doi.org\/10.1097\/WCO.0000000000000640.","journal-title":"Curr Opin Neurol"},{"issue":"2","key":"4044_CR4","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1161\/STROKEAHA.123.044533","volume":"55","author":"B Largeau","year":"2024","unstructured":"Largeau B, Bergeron S, Auger F, Salmon Gandonni\u00e8re C, Jonville-B\u00e9ra AP, Ehrmann S, et al. Experimental models of posterior reversible encephalopathy syndrome: a review from pathophysiology to therapeutic targets. Stroke. 2024;55(2):484\u201393. https:\/\/doi.org\/10.1161\/STROKEAHA.123.044533.","journal-title":"Stroke"},{"key":"4044_CR5","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.pediatrneurol.2019.07","volume":"103","author":"A Thavamani","year":"2020","unstructured":"Thavamani A, Umapathi KK, Puliyel M, Super D, Allareddy V, Ghori A. Epidemiology, comorbidities, and outcomes of posterior reversible encephalopathy syndrome in children in the United States. Pediatr Neurol. 2020;103:21\u20136. https:\/\/doi.org\/10.1016\/j.pediatrneurol.2019.07.","journal-title":"Pediatr Neurol"},{"issue":"8","key":"4044_CR6","doi-asserted-by":"publisher","first-page":"e391","DOI":"10.1097\/RHU.0000000000001470","volume":"27","author":"A Manadan","year":"2021","unstructured":"Manadan A, Kambhatla S, Gauto-Mariotti E, Okoli C, Block JA. Rheumatic diseases associated with posterior reversible encephalopathy syndrome. J Clin Rheumatol. 2021;27(8):e391\u20134. https:\/\/doi.org\/10.1097\/RHU.0000000000001470.","journal-title":"J Clin Rheumatol"},{"issue":"9","key":"4044_CR7","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1177\/0961203313496341","volume":"22","author":"SM Jung","year":"2013","unstructured":"Jung SM, Moon SJ, Kwok SK, Ju JH, Park KS, Park SH, et al. Posterior reversible encephalopathy syndrome in Korean patients with systemic lupus erythematosus: risk factors and clinical outcome. Lupus. 2013;22(9):885\u201391. https:\/\/doi.org\/10.1177\/0961203313496341.","journal-title":"Lupus"},{"issue":"3","key":"4044_CR8","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1007\/s10067-017-3892-2","volume":"37","author":"U Damrongpipatkul","year":"2018","unstructured":"Damrongpipatkul U, Oranratanachai K, Kasitanon N, Wuttiplakorn S, Louthrenoo W. Clinical features, outcome, and associated factors for posterior reversible encephalopathy in Thai patients with systemic lupus erythematosus: a case-control study. Clin Rheumatol. 2018;37(3):691\u2013702. https:\/\/doi.org\/10.1007\/s10067-017-3892-2.","journal-title":"Clin Rheumatol"},{"issue":"2","key":"4044_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2020.102739","volume":"20","author":"M Valdez-L\u00f3pez","year":"2021","unstructured":"Valdez-L\u00f3pez M, Aguirre-Aguilar E, Vald\u00e9s-Ferrer SI, Mart\u00ednez-Carrillo FM, Arauz A, Barrera-Vargas A, et al. Posterior reversible encephalopathy syndrome: a neuropsychiatric manifestation of systemic lupus erythematosus. Autoimmun Rev. 2021;20(2):102739. https:\/\/doi.org\/10.1016\/j.autrev.2020.102739.","journal-title":"Autoimmun Rev"},{"issue":"9","key":"4044_CR10","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1016\/S1474-4422(15)00111-8","volume":"14","author":"JE Fugate","year":"2015","unstructured":"Fugate JE, Rabinstein AA. Posterior reversible encephalopathy syndrome: clinical and radiological manifestations, pathophysiology, and outstanding questions. Lancet Neurol. 2015;14(9):914\u201325. https:\/\/doi.org\/10.1016\/S1474-4422(15)00111-8.","journal-title":"Lancet Neurol"},{"issue":"4","key":"4044_CR11","doi-asserted-by":"publisher","first-page":"217","DOI":"10.5152\/TurkPediatriArs.2016.2192","volume":"51","author":"S Emeksiz","year":"2016","unstructured":"Emeksiz S, Kutlu NO, \u00c7aksen H, Alkan G, Y\u0131kmaz H\u015e, Tokg\u00f6z H. Posterior reversible encephalopathy syndrome in children: a case series. Turk Pediatri Ars. 2016 1;51(4):217\u201320. https:\/\/doi.org\/10.5152\/TurkPediatriArs.2016.2192.","journal-title":"Turk Pediatri Ars"},{"issue":"1","key":"4044_CR12","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s00134-012-2705-y","volume":"39","author":"TH Chen","year":"2013","unstructured":"Chen TH, Chiou SS, Lin WC, Wang IF, Chen IC, Dai ZK, et al. Posterior reversible encephalopathy syndrome in critically ill children: a case series. Intensive Care Med. 2013;39(1):155\u20136. https:\/\/doi.org\/10.1007\/s00134-012-2705-y.","journal-title":"Intensive Care Med"},{"issue":"5","key":"4044_CR13","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1177\/09612033221088207","volume":"31","author":"R Baisya","year":"2022","unstructured":"Baisya R, Kumar Devarasetti P, Narayanan R, Rajasekhar L. Posterior reversible encephalopathy syndrome in juvenile lupus- a case series and literature review. Lupus. 2022;31(5):606\u201312. https:\/\/doi.org\/10.1177\/09612033221088207.","journal-title":"Lupus"},{"issue":"12","key":"4044_CR14","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1007\/s10067-015-3055-2","volume":"34","author":"A Budhoo","year":"2015","unstructured":"Budhoo A, Mody GM. The spectrum of posterior reversible encephalopathy in systemic lupus erythematosus. Clin Rheumatol. 2015;34(12):2127\u201334. https:\/\/doi.org\/10.1007\/s10067-015-3055-2.","journal-title":"Clin Rheumatol"},{"issue":"8","key":"4044_CR15","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1177\/0961203307079811","volume":"16","author":"M Punaro","year":"2007","unstructured":"Punaro M, Abou-Jaoude P, Cimaz R, Ranchin B. Unusual neurologic manifestations (part II): posterior reversible encephalopathy syndrome (PRES) in the context of juvenile systemic lupus erythematosus. Lupus. 2007;16(8):576\u20139. https:\/\/doi.org\/10.1177\/0961203307079811.","journal-title":"Lupus"},{"issue":"12","key":"4044_CR16","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1177\/08830738050200121201","volume":"20","author":"H Ozyurek","year":"2005","unstructured":"Ozyurek H, Oguz G, Ozen S, Akyuz C, Karli Oguz K, Anlar B, et al. Reversible posterior leukoencephalopathy syndrome: report of three cases. J Child Neurol. 2005;20(12):990\u20133. https:\/\/doi.org\/10.1177\/08830738050200121201.","journal-title":"J Child Neurol"},{"key":"4044_CR17","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.clineuro.2014.06.034","volume":"125","author":"PT Akins","year":"2014","unstructured":"Akins PT, Axelrod Y, Silverthorn JW, Guppy K, Banerjee A, Hawk MW. Management and outcomes of malignant posterior reversible encephalopathy syndrome. Clin Neurol Neurosurg. 2014;125:52\u20137. https:\/\/doi.org\/10.1016\/j.clineuro.2014.06.034.","journal-title":"Clin Neurol Neurosurg"},{"issue":"2","key":"4044_CR18","doi-asserted-by":"publisher","first-page":"102739","DOI":"10.1016\/j.autrev.2020.102739","volume":"20","author":"M Valdez-L\u00f3pez","year":"2021","unstructured":"Valdez-L\u00f3pez M, Aguirre-Aguilar E, Vald\u00e9s-Ferrer SI, Mart\u00ednez-Carrillo FM, Arauz A, Barrera-Vargas A, et al. Posterior reversible encephalopathy syndrome: a neuropsychiatric manifestation of systemic lupus erythematosus. Autoimmun Rev. 2021;20(2):102739. https:\/\/doi.org\/10.1016\/j.autrev.2020.102739.","journal-title":"Autoimmun Rev"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-04044-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-025-04044-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-04044-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T13:06:08Z","timestamp":1762520768000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-025-04044-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,7]]},"references-count":18,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4044"],"URL":"https:\/\/doi.org\/10.1186\/s13023-025-04044-0","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,7]]},"assertion":[{"value":"12 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was obtained from the patients for drafting the manuscript and the research follows ethical guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors read the fnal manuscript and approved it for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publications"}},{"value":"The authors declare that they have no confict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"566"}}